Evidence map›Paper›PMID 38433170›Full record

ReviewWorld journal of microbiology & biotechnology2024

Bioprospecting photosynthetic microorganisms for the removal of endocrine disruptor compounds.

Birgitta Narindri Rara Winayu, Feng-Jen Chu, Christoper Caesar Yudho Sutopo, Hsin Chu

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Birgitta Narindri Rara WinayuDepartment of Environmental Engineering, National Cheng Kung University, Tainan, 70101, Taiwan.
Feng-Jen ChuSchool of Medicine, Anhui University of Science and Technology, Huainan, 232001, Anhui, China.
Christoper Caesar Yudho SutopoDepartment of Tropical Agriculture and International Cooperation, National Pingtung University of Science and Technology, Pingtung, 91201, Taiwan.
Hsin ChuDepartment of Environmental Engineering, National Cheng Kung University, Tainan, 70101, Taiwan. chuhsin@mail.ncku.edu.tw.

Funding

National Science and Technology Council NSTC-112-2811-E-006-014
6 · The paper itself

Abstract

Endocrine disruption compounds can be found in various daily products, like pesticides, along with cosmetic and pharmaceutical commodities. Moreover, occurrence of EDCs in the wastewater alarms the urgency for their removal before discharge owing to the harmful effect for the environment and human health. Compared to implementation of physical and chemical strategies, cultivation of photosynthetic microorganisms has been acknowledged for their high efficiency and eco-friendly process in EDCs removal along with accumulation of valuable byproducts. During the process, photosynthetic microorganisms remove EDCs via photodegradation, bio-adsorption, -accumulation, and -degradation. Regarding their high tolerance in extreme environment, photosynthetic microorganisms have high feasibility for implementation in wastewater treatment plant. However, several considerations are critical for their scaling up process. This review discussed the potency of EDCs removal by photosynthetic microorganisms and focused on the efficiency, mechanism, challenge, along with the prospect. Details on the mechanism's pathway, accumulation of valuable byproducts, and recent progress in scaling up and application in real wastewater were also projected in this review.

Indexed as

Endocrine DisruptorsAdsorptionBioprospectingHumansPhotosynthesisWastewaterEndocrine DisruptorsWastewaterBioprospectCyanobacteriaEDCs removalMicroalgaePhotosynthetic microorganismsRemoval pathway

Identifiers

PMID38433170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.